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Syndome (SARS)
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M. Ho, B. Cowling, and A. J. Hedley
Abstract
For diseases with some level of associated mortality, the case fatality ratio mea-
sures the proportion of diseased individuals who die from the disease. In princi-
ple, it is straightforward to estimate this quantity from individual follow-up data
that provides times from onset to death or recovery. In particular, in a compet-
ing risks context, the case fatality ratio is defined by the limiting value of the
sub-distribution function, associated with death, at infinity. When censoring is
present, however, estimation of this quantity is complicated by the possibility of
little information in the right tail of of the sub-distribution function, requiring use
of estimators evaluated at large or the largest observed death times. With right
censoring, the variability of such estimators is large in the tail, suggesting the pos-
sibility of using estimators evaluated at smaller death times where bias may be
increased but overall mean squared error be smaller. These issues are investigated
here for nonparametric estimators of the sub-distribution functions for both death
and recovery. The ideas are illustrated on case fatality data for individuals infected
with severe acute respiratory syndrome (SARS) in Hong Kong in 2003.
1 Introduction
The case fatality ratio (CFR) of a disease measures the proportion of aicted individuals
who die from the disease. For infectious or other acute diseases, the CFR is an important
measure of virulence, and is often used to assess the eect of cofactors and intervention
strategies. In the early stages of an epidemic, estimation of the CFR is complicated by the
fact that the disease may not have run its course in many aected individuals at the time
of analysis; that is, the times to death or recovery are right censored. The implications of
this are best understood in the context of a competing risks model.
Suppose the outcome of a disease is either death or recovery, and let the random vari-
ables T and J measure the time from initiation (e.g., infection) until the nal outcome, and
result of outcome (say J = 1 corresponds to death, and J = 2 to recovery), respectively.
The two sub-distribution functions of primary interest are
Fj(t) = pr(T  t; J = j); j = 1; 2
with the overall survival function given by
S(t) = pr(T > t) = 1− F1(t)− F2(t);
measuring the probability of neither recovering nor dying by time t. (Note that the standard
survival analysis terminology is unfortunate here since ‘survival’ up to time t in this context
means that no event has occurred by time t, and not recovery.) The CFR is then simply
dened by limt!1 F1(t) = pr(J = 1), the proportion of diseased individuals who eventually
die; for simplicity we refer to the CFR by F1(1).
We suppose that, for each individual, information on survival status is available subject
to independent right censoring at time C. Thus, the observed data can be represented as
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Y = ( ~T ;;J), where ~T = min(T;C) and  = 1 if T < C and is 0 otherwise. We assume
that the censoring random variable C follows an unknown distribution function G. In x2
we briefly review nonparametric procedures for estimation of F1(t) and F2(t), leading to
estimators F^1(t) and F^2(t). The presence of right censoring complicates nonparametric esti-
mation of F1(1) as information on the value of F1 may run out before the sub-distribution
function has reached its asymptotic limit. Given this obstacle, two estimation strategies
are possible given nonparametric estimates of F1 and F2. First, we can simply estimate
F1(1) by
CFRa = F^1(t
)
for a suitably chosen large value t (perhaps, the largest observed death time). An alter-
native estimator is given by
CFRb =
F^1(t
)
F^1(t) + F^2(t)
;
for a similarly large t (perhaps, the largest observed outcome time, whether death or
recovery). The rst of these estimators ignores the fact that individuals may die after time
t, and the second assumes that the proportion of individuals, still aicted at time t, who
ultimately die is the same as observed for those whose outcome occurs prior to t. In either
case, understanding the influence curve for the original estimators F^1 and F^2 allows the
derivation of the asymptotic variance of either of these two estimators of the CFR. In x2, we
introduce two familiar nonparametric strategies for estimation of F1 and F2, and calculate
the asymptotic variances of both CFRa and CFRb based on these sub-distribution function
estimators.
These two strategies for estimation of the CFR are analogies to two estimates based
on group rather than individual data; that is, where only the total number of deaths and
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recoveries are known by a xed follow-up or censoring time C. The naive estimate of the
CFR as the fraction of all aicted individuals who die by time C is clearly subject to bias,
particularly if the xed time C is small relative to the upper bound of the support of T . The
second approach suggests the use of the fraction of deaths amongst those whose outcome
is known at time C. For grouped SARS data, the second approach was recommended by
several authors (Donnelly et al, 2003; Galvani et al, 2003) and the two methods have been
compared on simulated data (Ghani et al, 2004).
For either CFRa or CFRb, choosing t
 large enough is important in reducing bias; how-
ever, in the presence of substantial right censoring, nonparametric estimators of F^1 and F^2
suer from increased variability for large t. These two observations suggest that the value
t might be chosen somewhat smaller, trading an increase in bias for decreased variance in
order to reduce mean squared error. In x2.4 we suggest a data adaptive procedure for its
selection. In x3 we use some limited simulations to assess the performance of estimators
of CFRa and CFRb, and also compare dierent estimators of their sampling variability,
namely (i) the (asymptotic) estimated variance based on influence curve calculations, (ii)
a Greenwood-type estimator of the asymptotic variance, (iii) a simple bootstrap variance
estimate, and (iv) an asymptotic approximation suggested by D. R. Cox (Donnelly et al,
2003; Ghani et al, 2004). Finally, in x4, the ideas are illustrated on data from SARS
patients in Hong Kong in Spring 2003 (Donnelly et al, 2003; Ghani et al, 2004).
4
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2 Nonparametric Estimates of F1 and F2 and Their
Asymptotic Variances
Two basic strategies are available for nonparametric estimation of F1 and F2. To describe
and compare these we rst require some notation. Let t1 <    < tk denote the distinct
observed event times for outcomes of either type, with dij representing the number of
outcomes of type j that occur at time ti, and ni the number of subjects at risk at time ti.
The rst estimator is nonparametric maximum likelihood, yielding:
F^1(t)ML =
X
tit
di1
ni
S^(ti
−); (1)
with an analogous expression for F^2(t)ML (Kalbfleisch and Prentice, 2002, Chapter 8.2),
where S^ is just the Kaplan-Meier estimator of the overall survival function.
For complete data (T; J), the nonparametric maximum likelihood estimator of F1 is the
empirical sub-distribution function given by n−1
Pn
i=1 I(Ti  t; J = 1), where I(E) is the
indicator function for the event E represented by its argument. With censored data this
suggests using this estimator for the observed complete (that is, uncensored) observations,
weighted by the probability of not being censored. This inverse probability of censoring
weighted estimator is therefore given by
F^1(t)IPCW =
1
n
nX
i=1
I(ti  t; J = 1)i
1− G^(ti)
;
where G^ is an estimator of the censoring distribution function G, say, the nonparamet-
ric maximum likelihood (Kaplan-Meier) estimator. Again, an analogous denition yields
F^2(t)IPCW . Straightforward algebra establishes that, in fact, F^1(t)ML = F^1(t)IPCW , with
a similar equivalence for the two estimators of F2. From this point, we therefore refer to
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either estimator as F^1(t) and, similarly, F^2(t). The estimator (1) and its analogue for F2
are special cases of the Aalen-Johansen estimator (Aalen & Johansen, 1978), previously
developed for competing risks data by Aalen (1978).
2.1 Influence Curves and Asymptotic Variance Estimation for
CFRa
Based on the observed data Y = ( ~T ;;J), F^1(t) is an asymptotically linear estimator of
F1(t) with influence curve IC1(Y ) meaning that F^1(t)− F1(t) can be approximated by an
empirical mean of IC1(Y ):
F^1(t)− F1(t) = 1
n
nX
i=1
IC1(Y ) + oP (1=
p
n):
Further, if the full data X = (T; J; C) is subject to an observation process that is coarsened
at random (CAR), that is, given the full data X, the coarsening mechanism only depends
on the observed data (van der Laan and Robins, 2003, Chapter 1), then, from van der
Laan & Robins (2003, 3.19, pp. 195-6) the ecient influence curve for estimation of F1(t)
is given by
ICeff(Y ) =
(I(Y  t; J = 1)− F1(t))
G(T )
(2)
+
Z ~T
0
P (T  t; J = 1jT  u)− F1(t)
G(u)
dMG(u)
where G(T ) = 1−G(T ), and
dMG(u) = I( ~T 2 du;  = 0)− I( ~T  u)G(du);
with G denoting the cumulative hazard function associated with G.
6
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It remains to establish that IC1  ICeff . However this immediately follows from the
fact that F^1 is the nonparametric maximum likelihood estimator under CAR and is also
asymptotically linear (Gill et al, 1997).
We thus have established that
p
n(F^1(t) − F1(t)) converges in distribution to a nor-
mal distribution with mean zero and variance 21 = EfICeff(Y )ICeff(Y )g. In princi-
pal, this asymptotic variance can be estimated consistently in nite samples with ^21 =
1
n
Pn
i=1
^ICeff(Yi)
2, where (Ti; Ji); F^1; G^ are substituted in (1) for (T; J); F1 and G, respec-
tively, to obtain ^ICeff(Yi). This variance estimator can then used to construct a 95%
condence interval for F1(t):
F^1(t) 1:96 ^1p
n
:
The influence curve for F^2(t), its asymptotic variance and an associated estimator, are
determined in an analogous way.
It is well-known that plug-in estimators of the variance of an influence curve may
not perform well in nite samples. In this simple case of competing risks, there is a
more eective estimator of 21 given by the generalization of Greenwood’s formula to the
competing risk setting (Aalen & Johansen, 1978) which we now describe briefly (see also
Andersen et al., 1993, Example IV.4.1, pp. 298{304).
First, we introduce some necessary notation. For j = 1; 2, let F0j(s; t) denote the
probability that an individual alive at time s will have failed due to cause J = j by time t.
Similarly, let F00(s; t) be the probability that an individual alive at time s is still alive at
time t. (Note that, in the SARS example, alive refers to being infected, and failure refers
to either recovery or death.) In particular, F0j(0; t) = Fj(t) and F00(0; t) = S(t). Then,
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using nonparametric maximum likelihood, we have the estimators
F^00(s; t) =
Y
s<tit

1− di
ni

where di = di1 + di2, and
F^0j(s; t) =
X
s<tit
dij
ni
F^00(s; t
−
i ):
Then, following Andersen et al. (1993, 4.4.18), a consistent estimator of the covariance of
the estimators F^1(t) and F^2(t) is given by
dCov F^1(t); F^2(t) = −X
tit
S^2(t−i )f1− F^01(ti; t)gF^02(ti; t)
(ni − 1)
n3j
di1 (3)
−
X
tit
S^2(t−i )F^01(ti; t)(1− F^02(ti; t))
(ni − 1)
n3i
di2:
Further, a Greenwood estimate of the asymptotic variance of F^j(t) is given by
dV ar F^j(t) =X
tit
[S^(t−i )F^0j(ti; t)]
2(ni − 1)
n3i
(di1+di2)+
X
tit
S^2(t−i )[1−2F^0j(ti; t)]
(ni − 1)
n3i
dij:
(4)
Note that variance estimates based on either the influence curve, or Greenwood’s for-
mula, are used to approximate the variance of F^1(t) at a xed time point t. As described in
x1, the estimate CFRa is based on F^1(t) at a perhaps randomly selected time t, as when
using the largest observed death time. However, the asymptotic variance estimators do not
account for variability associated with determination of t. This is not the case with the
bootstrap estimate of the variance of F^1(t
) considered in the simulations of x4.
Finally, the influence curve of F^1(t), and thus its variance, involve the term G() in the
denominators of each term of (1). As such, we can expect both the asymptotic variance of
F^1(t) to be large in the ‘tail’ where G(t) is close to zero, and that the limit approximation
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may also be poor, particularly if the influence curve estimator ^1 is used. Unfortunately,
minimizing bias suggests choosing t as large as possible when using F^1(t) in CFRa. How-
ever, possible deterioration of the variance motivates using a smaller value of t. This is
explored further in x3 and in the simulations.
2.2 Influence Curves and Asymptotic Variance Estimation for
CFRb
Simple algebra shows that:
F^1(t)
F^1(t) + F^2(t)
− F1(t)
F1(t) + F2(t)
=
1
F (t)
(F^1(t)− F1(t))− F^1(t)
F^ (t)F (t)
(F^ (t)− F (t))
where F (t) = F1(t) + F2(t) and F^ (t) = F^1(t) + F^2(t).
Thus, for xed t, the influence curve, IC, for F^1(t)
F^1(t)+F^2(t)
as an estimator of F1(t)
F1(t)+F2(t)
depends straightforwardly on the influence curves of F1(t) and F2(t):
IC(Yi) =
1
F (t)
IC1(Yi)− F1(t)
[F (t)]2
(IC1 + IC2)(Yi): (5)
An estimate of IC(Yi) is obtained by plugging in the empirical estimates of IC1(Yi)
and IC2(Yi) discussed in x2.1. Similarly, we can estimate the asymptotic variance 2 of
F^1(t)
F^1(t)+F^2(t)
by ^2 = 1
n
Pn
i=1
^IC(Yi)
2, with an associated 95% condence interval for F1(t)
F1(t)+F2(t)
given by:
F^1(t)
F^1(t) + F^2(t)
 1:96 ^p
n
An alternative, and likely more reliable, estimator of the asymptotic variance of CFRb
can be based on the Greenwood formulae (3) and (4) together with application of the delta
9
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method which gives
cvar F^1(t)
F^1(t) + F^2(t)
!
=
[F^2(t)]
2var

F^1(t)

+ [F^1(t)]
2var

F^2(t)

− 2F^1(t)F^2(t)ccovF^1(t); F^2(t)
F^1(t) + F^2(t)
4 :
(6)
As discussed with CFRa, caution should be exercised towards using such estimates for
the variance of CFRb at a randomly selected t
 instead of a xed t.
2.3 The Cox Approximation for 2
By ignoring certain correlation terms, D. R. Cox suggested a clever approximation to the
asymptotic variance of CFRb (see Ghani et al, 2004) that has been used as an alternative to
either the influence curve or Greenwood-type variance estimators. Noting that log S^(t) =P
ti<t
log(1− h^i), where h^i  dini , it follows from the delta method that ccovS^(s); S^(t) =
S^(s)S^(t)
P
ti<s
di
ni(ni−di) for s  t estimates the asymptotic covariance of the Kaplan-Meier
estimator at two times s and t. Cox suggested ignoring the covariance between h^ij =
dij
ni
and S^(tk
−) for any i; j; k, so that we can again use the delta method on (1) to yield
cvarF^1(t) = h1Ωh1T +X
tit
S^(ti
−)2
di(ni − di)
ni3
; (7)
where h1 =

h^11; : : : ; h^k1

with tk being the largest event time less than or equal to
t, and Ω is the variance-covariance matrix of Sk 

S^(t1
−); : : : ; S^(tk−)

. A analogous
approximation obtains for cvarF^2(t) with similar notation. We note in passing that this
provides a simple approximation to the variance of CFRa, although it is unlikely to be as
accurate as the extension of Greenwood’s formula.
10
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By the same approach, we also obtain the approximation
ccovF^1(t); F^2(t) = h1Ωh2T + SkΨSkT ;
where Ψ is an estimate of the asymptotic variance-covariance matrix of the vectors h1 and
h2, thus given by a diagonal matrix with (i; i) entry equal to −di1di2ni2 . A nal application
of the delta method, using (6), gives the nal formula for the estimate of the asymptotic
variance of cvar F^1(t)
F^1(t)+F^2(t)

.
We note that Ghani et al (2004) ignore certain \second order" terms so that they take
the summand in the second term of (7) to be S^(ti
−)2 di
ni2
and Ψ = 0; we use this version in
the rest of the article.
2.4 Choosing the Value of t
To minimize bias, it is natural to use the largest observed death and/or recovery time for
t in constructing the estimators CFRa and CFRb; to emphasize the dependence on the
choice of t in these estimators, we here denote them, respectively, by CFRa(tmax) and
CFRb(tmax). On the other hand, at these observed values of t, the associated standard
errors are likely to be large, as the probability of censoring is high. It is plausible that
the mean squared error of these estimators might be improved by selecting a smaller value
of t in CFRa(t) and CFRb(t) in order to substantially decrease variability at the cost of
admitting some extra bias. Further, it is possible to consider a data-adaptive choice of an
‘optimal’ t, selected to minimize mean squared error in this way.
Suppose, for example, that tmax is the largest observed death time. For t < tmax, the
11
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mean squared error of F^1(t) as an estimate of CFR can, in turn, be estimated by
fF^1(t)− F^1(tmax)g2 + f^21(t)g; (8)
where ^21(t) estimates the variance of the estimator of x2.1 at the value t. The ‘optimal’
time to estimate CFR, topt, is then selected to be that value of t that empirically minimizes
(8). A similar approach can be used to choose an optimal t when using CFRb; it is likely
that the two optimal values dier. We emphasize that use of the variance estimate ^21(topt)
ignores variability associated with the random choice of topt. The simulations of x4 provide
insight into when use of topt, in place of tmax, is likely to be of value.
3 Simulations
A limited simulation study was employed to compare the performance of CFRa and CFRb,
and to assess the value in estimating the case fatality ratio at topt as compared to tmax.
We consider three dierent scenarios, characterized by diering censoring patterns. In the
motivating example of an epidemic, the censoring distribution is generated by the arrival
pattern in time of newly infected cases in relation to the chronological time of data analysis.
The three scenarios thus, in part, reflect analysis of outcome data at diering times in the
course of an epidemic. We specify the joint distribution of (T; J) through the CFR and the
two conditional distributions of T , given J = 1 and given J = 2.
The simulation parameters were motivated by the parametric approximation of SARS
data used by Donnelly et al (2003). For each scenario, the true CFR is set to be 0.2,
with conditional outcome distributions both Gamma, with means 35 and 25 for death
and recovery, respectively, with both having variance 200. In Scenario I, the censoring
12
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distribution is Uniform on [0; 100], yielding an overall probability of censoring of about
30%. In Scenario II, the censoring distribution is a mixture of a Uniform distribution on
(0; 50) (with probability 0.2) and, beyond 50, an Exponential distribution (with origin at
50) with a rate parameter of 0:2 (with probability 0.8)|this yields an overall probability
of censoring of about 19%. Finally the censoring distribution for Scenario III is similar to
that for Scenario II, except that the change point between the Uniform and Exponential
distributions occurs at 30 rather than 50, and beyond 30 the Exponential distribution has
rate parameter 0.1, these changes yielding a higher overall censoring probability of about
36%. For the three scenarios, Figures 1{3 display the survival distribution corresponding
to censoring, G(t), together with F1(t) and
F1(t)
F1(t)+F2(t)
. With regard to data arising from an
epidemic, Scenario I is intended to reflect an analysis at a mature state of the epidemic with
a substantial amount of complete information on death or recovery; Scenario III, on the
other hand, mimics an analysis much earlier in an epidemic so that many observations are
censored before information is available on death or recovery. Scenario II is intermediate
between these two situations.
For each scenario 1,000 data sets of two extremes of sample size were simulated, one
with n = 100, and the other with n = 1; 500, the latter case roughly corresponding with
the Hong Kong SARS data considered in x4. For each simulation, the estimators, CFRa
and CFRb at tmax, and CFRb at the data-driven optimal topt (as described in x3) and
their estimated variances (based on the appropriate influence curve, Greenwood formula,
Cox approximation or bootstrap for CFRa and CFRb; only the Greenwood formula and
Cox approximation for CFRb at topt for computational reasons) were computed. Either
the Greenwood formula or the Cox approximation was used in evaluating estimated mean
squared error in choosing the value topt for each data set. For the bootstrap variance
13
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Figure 1: Description of the Sub-Distribution Function F1 and Ratio
F1
F1+F2
and Censoring Distribution G for Simulation Scenario I
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Figure 2: Description of the Sub-Distribution Function F1 and Ratio
F1
F1+F2
and Censoring Distribution G for Simulation Scenario II
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Figure 3: Description of the Sub-Distribution Function F1 and Ratio
F1
F1+F2
and Censoring Distribution G for Simulation Scenario III
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Table 1: Comparison of Estimators of the Case Fatality Ratio in Three
Simulation Scenarios (n = 100)
Scenario Estimator Simulation Simulation Simulation Mean
Mean Variance of Variance Estimators
IC bootstrap Cox Greenwood
I CFRa(tmax) 0.1855 0.002828 0.002821 0.002733 0.004435 0.002418
CFRb(tmax) 0.1912 0.002841 0.002410 0.002739 0.002871 0.003452
CFRb(topt) 0.1764 0.002611 0.001040
0.1756 0.002937 0.002498
II CFRa(tmax) 0.1550 0.002612 0.004124 0.002061 0.003558 0.001756
CFRb(tmax) 0.1644 0.002555 0.003147 0.002138 0.002549 0.002832
CFRb(topt) 0.1480 0.002033 0.000693
0.1462 0.002236 0.001902
III CFRa(tmax) 0.1486 0.007459 0.011632 0.004613 0.007380 0.003039
CFRb(tmax) 0.1583 0.007270 0.006031 0.004603 0.004764 0.003887
CFRb(topt) 0.1353 0.005348 0.000780
0.1328 0.005628 0.001688
estimator, 200 bootstrap samples with replacement were generated; since tmax will vary
across these pseudo-samples, this method accounts for this form of variation unlike the
other methods. For the two sample sizes, n = 100 and 1; 500, the simulation mean and
variance of three estimators are reported in Tables 1 & 2, respectively, together with the
simulation mean of corresponding variance estimators.
Generally, CFRa exhibits a little more bias and variability than CFRb, as can be ex-
pected from the shapes of F1 and
F1
F1+F2
as illustrated in Figures 1{3. For all estimators,
the bias is worst in Scenarios II and III where there is heavier censoring in the tail of F1
17
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Table 2: Comparison of Estimators of the Case Fatality Ratio in Three
Simulation Scenarios (n = 1; 500)
Scenario Estimator Simulation Simulation Simulation Mean
Mean Variance of Variance Estimators
IC bootstrap Cox Greenwood
I CFRa(tmax) 0.1955 0.000198 0.010188 0.000194 0.000233 0.000168
CFRb(tmax) 0.1966 0.000194 0.001625 0.000191 0.000153 0.000239
CFRb(topt) 0.1948 0.000190 0.000127
0.1953 0.000190 0.000230
II CFRa(tmax) 0.1772 0.000577 0.026347 0.000411 0.000254 0.000192
CFRb(tmax) 0.1822 0.000484 0.012964 0.000355 0.000180 0.000245
CFRb(topt) 0.1775 0.000374 0.000118
0.1776 0.000372 0.000202
III CFRa(tmax) 0.1815 0.000997 0.117507 0.000804 0.000340 0.000327
CFRb(tmax) 0.1856 0.000879 0.003912 0.000728 0.000247 0.000367
CFRb(topt) 0.1817 0.000795 0.000147
0.1815 0.000802 0.000207
and F2. The estimator, CFRb, evaluated at topt, is more biased as expected, but also
displays the anticipated gains in precision. Figures 4{6 show the behavior of bias squared,
variance, and mean squared error for typical data sets with n = 100 in the three simulation
scenarios.
For n = 100, the simulation means of the four variance estimators are all reasonably
close to their actual variance, with somewhat better performance for CFRb than for CFRa.
For CFRb evaluated at topt, the Cox approximation does not perform as well with a
tendency to substantially underestimate variability in Scenarios II and III as compared to
the Greenwood estimator.
For n = 1; 500, the situation is now qualitatively similar although here the influence
curve method substantially overstates the variability in all three scenarios, presumably be-
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Figure 4: Empirical Estimates of the Bias Squared, Variance and Mean
Squared Error of CFRb Evaluated at Times t Lower than tmax for Sim-
ulation Scenario I
Time
30 40 50 60
0.
0
0.
00
5
0.
01
0
0.
01
5
0.
02
0
0.
02
5
0.
03
0
MSE
Bias squared
Variance
19
http://biostats.bepress.com/ucbbiostat/paper176
Figure 5: Empirical Estimates of the Bias Squared, Variance and Mean
Squared Error of CFRb Evaluated at Times t Lower than tmax for Sim-
ulation Scenario II
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Figure 6: Empirical Estimates of the Bias Squared, Variance and Mean
Squared Error of CFRb Evaluated at Times t Lower than tmax for Sim-
ulation Scenario III
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cause estimates are made further out in the tail of F1 and F2 as evidenced by the lower
bias throughout with the higher sample size. The bootstrap method continues to exhibit
reasonable performance, outperforming both the Greenwood estimator and the Cox ap-
proximation which, while much better than the influence curve calculation, signicantly
underestimate the true variance of estimators. As with the smaller sample size, the under-
estimation associated with the Cox approximation is even greater in estimating the variance
of CFRb evaluated at topt.
Overall, the results support preference for the estimator CFRb here, with only marginal
improvement when evaluating it at topt as against tmax. For variance estimation, the
bootstrap method is most eective; plug-in evaluation of the influence curve variance cannot
be recommended in general. The Cox approximation is surprisingly competitive with the
Greenwood formula although both exhibit a tendency to underestimate the true variability,
particularly when evaluated at topt.
4 Application to SARS Data
Severe Acute Respiratory Syndrome (SARS) caused by a previously unknown coronavirus,
infected over 8,000 people worldwide during 2003. The source of infection of SARS in
Hong Kong was traced to an infected Guangzhou professor who arrived in Hong Kong in
late February 2003. The analyses here are based on subsamples of the complete record of
1755 SARS cases in Hong Kong as dened by the WHO clinical case denition. Further
epidemiological details for these cases are given in Donnelly et al (2003) and Leung et al
(2004).
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Since the data here contain only those admitted to hospital, the date of the latter event
is used as the time origin rather than the date of infection, and 124 cases were excluded
as they were admitted to hospital prior to SARS onset. The date of recovery refers to
the date of discharge from the acute care hospital|no recovered individuals subsequently
died of SARS-related causes. A further 25 cases were not used because either their nal
outcome or discharge date was unknown. To illustrate the estimators and their associated
variability, we analyze the data as they would have been observed at seven dierent time
points, bi-weekly starting with April 2, 2003, during which period the epidemic almost
doubled in size.
Table 3 provides the estimates CFRa and CFRb, along with various variability esti-
mates, at each of the seven times noted (as before we used 200 bootstrap samples with
replacement). As background, the mean time to outcome (death or recovery) was a little
more than three weeks. The epidemic of infections peaked in late March, but given the lag
time between infection and outcome, 86% of existing case outcomes remained unknown at
the beginning of April, reflecting very heavy censoring for the earliest analyses of Table 3.
We note that the estimate CFRb was relatively stable after late April, with a value
of 14.2% for the analysis of May 14. The alternative estimator CFRa gave slightly lower
values. With the simulation evidence of x3 for similar shapes for F1 and F2, the estimator
CFRb is preferred here. We note that the case fatality ratio 14.2% is lower than the nal
reported value of 17.2% for Hong Kong, the discrepancy largely due to the exclusion of the
124 patients who contracted SARS after admission to hospital, a group that displayed a
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Table 3: Various Estimates of the Case Fatality Rate for SARS at Different
Time Points During the 2003 Hong Kong Epidemic
Apr 2 Apr 9 Apr 16 Apr 23 Apr 30 May 7 May 14
Sample size 929 1198 1352 1466 1524 1558 1583
CFRa(tmax) 0.0743 0.0640 0.0832 0.1068 0.1220 0.1347 0.1370cvar(CFRa)(IC) 0.08801 0.03500 0.02728 0.01490 0.00518 0.00206 0.00074cvar(CFRa)(Cox) 0.00064 0.00024 0.00020 0.00022 0.00015 0.00014 0.00013cvar(CFRa)(Gwood) 0.00020 0.00013 0.00013 0.00014 0.00011 0.00010 0.00009
CFRb(tmax) 0.0743 0.0743 0.0971 0.1220 0.1334 0.1422 0.1419cvar(CFRb)(IC) 0.00310 0.00234 0.00033 0.00087 0.00043 0.00026 0.00015cvar(CFRb)(Cox) 0.00078 0.00031 0.00024 0.00023 0.00015 0.00012 0.00011cvar(CFRb)(Gwood) 0.00026 0.00027 0.00028 0.00026 0.00020 0.00019 0.00017cvar(CFRb)(bootstrap) 0.00079 0.00034 0.00026 0.00021 0.00013 0.00011 0.00010
CFRb(topt)(Cox) 0.0664 0.0726 0.0893 0.1219 0.1310 0.1419 0.1401cvar(CFRb(topt))(Cox) 0.00040 0.00029 0.00019 0.00020 0.00013 0.00012 0.00010
topt(days) 18 24 18 19 33 57 52
CFRb(topt)(Gwood) 0.0668 0.0678 0.0934 0.1163 0.1334 0.1419 0.1400cvar(CFRb(topt))(Gwood) 0.00019 0.00009 0.00014 0.00013 0.00015 0.00015 0.00014
topt(days) 18 17 23 26 32 40 42
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much greater case fatality ratio than the general population.
As anticipated from the simulation results of x3, the variance estimates from the Green-
wood formula, the Cox approximation, or the bootstrap appear much more reliable than
those based on simple estimation of the influence curve of CFRb, although the latter gives
acceptable results for the last analysis, at least for CFRb. There is little to choose here
between the Cox approximation and the bootstrap|both give very similar results. Finally,
bias quickly dominates gains in precision in choosing smaller values of time at which to
estimate the CFR so that here CFRb(topt) is close to CFRb, although there are noticeable
gains in precision for the earliest analyses. Finally, the simulations of x3 suggest that the
Greenwood formula is more relaible as an estimator of the associated cvar(CFRb(topt)) than
the Cox approximation, although it still likely underestimates the true variability.
5 Discussion
For the Hong Kong SARS data we have argued in favor of the estimator CFRb over CFRa.
While this preference remains reasonable when the cumulative sub-distributions of death
and recovery increase at a similar rate over time, this need not always be so. For example,
consider an alternative scenario where those patients, at risk of dying, tend to die very
quickly after infection, whereas it typically takes somewhat longer for recovery. In this
case, the death sub-distribution, F1 reaches its asymptote at a much smaller t, than F2.
Then, for low values of t (and therefore early in an epidemic) CFRb suers from much
greater bias than CFRa as illustrated in Figure 7.
Estimation of the relevant influence curve of a case fatality ratio estimator as the basis
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Figure 7: Description of the Sub-Distribution Functions F1, F2 and Ratio
F1
F1+F2
for Scenario Where Times to Death are Considerably Smaller than
to Recovery
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of a variance calculation is unreliable when there is substantial censoring. We note that
this does not contradict the expression of the asymptotic variance in terms of the influence
curve, only that simple plug-in estimators will not perform well unless G is away from zero.
Alternative estimators of the same asymptotic variance have much better performance.
This is not surprising in light of the standard Kaplan-Meier estimator where Greenwood’s
formula is much more stable than plug-in estimates of the influence curve under heavy
censoring. Both the Greenwood estimator and the Cox approximation are plausible alter-
natives in the situations considered here, although it remains to be proved that the latter
approximation is asymptotically correct. The bootstrap variance estimate is even more at-
tractive, although more computationally intensive. It appears as if the bootstrap technique
is picking up second order eects in variance estimation that are important in estimation
in the tails of the sub-distribution functions and that are missed by rst order asymptotic
estimators.
Evidence has already suggested that the case fatality ratio for SARS varies with other
patient cofactors, principally age, where the elderly suer from far greater case fatality
(Donnelly et al, 2003; Leung et al, 2004). The procedures studied here can be immediately
applied to subgroups of interest. Extending our results to regression analyses that allow
the case fatality ratio to vary continuously with an interval-scaled explanatory variable is a
topic that is currently being pursued using standard regression models for competing risks
data.
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